OGEN Oragenics
- 1.0700
- +0.0199+1.90%
- 1.0500
- -0.0200-1.87%
Oragenics News
Earnings Week Ahead: Disney, Palantir, Shopify, Uber, Plug Power and More
Oragenics, Inc. Announces Notification of Noncompliance With Additional NYSE American Continued Listing Standards
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards Download as PDF April 19, 2024SARASOTA, Fla.--(BUSINESS WIRE)-- Oragenics, Inc. (NY
Oragenics, Inc. Files 10K And Provides Company Update
Oragenics, Inc. (the "Company") (NYSE:OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it has filed its annua
Oragenics, Inc. Files 10K and Provides Company Update
Oragenics, Inc. Files 10K and Provides Company Update Download as PDF April 01, 2024SARASOTA, Fla.--(BUSINESS WIRE)-- Oragenics, Inc. (the "Company") (NYSE American: OGEN), a company focused on dev
Earnings Week Ahead: Walgreens Boots Alliance, Carnival, GameStop and More
Oragenics Appoints New CMO for Phase II TBI Drug Trial
Oragenics Appoints Kelly As Chief Medical Officer
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion Download as PDF March 05, 2024SARASOTA, Fla.--(BUSINESS WIRE)-- Oragenics, Inc. (NYSE American: OGEN), a company focus
Oragenics Inc Enhances Financial Standing With Equity Sale
Oragenics Announces Closing of Public Offering
Oragenics Announces Closing of Public Offering Download as PDF March 01, 2024SARASOTA, Fla.--(BUSINESS WIRE)-- Oragenics, Inc. (NYSE American: OGEN) ("Oragenics" or the "Company"), a company focuse
Top Midday Decliners
Integral Ad Science (IAS) reported Q4 earnings Tuesday of $0.06 per diluted share, down from $0.07 a year earlier. Truist adjusted the price target on the company's shares to $17 from $26 while mainta
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersVivani Medical (NASDAQ:VANI) stock increased by 314.4% to $4.19 during Wednesday's regular session. The company's market cap stands at $213.5 million. Adial Pharmaceuticals (NASDAQ:ADIL) stock
Oragenics Shares Tumble Premarket After Stock Offering
By Colin Kellaher Shares of Oragenics slid more than 40% in premarket trading Wednesday after the development-stage biotechnology company said it was raising $2.1 million in a dilutive public offerin
Oragenics Inc Announces Proposed Public Stock Offering
Oragenics Prices Public Offering Of 1.40 Mln Shares At $1.50/shr; Stock Plunges
Oragenics Intends to Use Proceeds to Fund Development of Neurosteroid Drug ONP-002 >OGEN
Oragenics Intends to Use Proceeds to Fund Development of Neurosteroid Drug ONP-002 >OGEN
ThinkEquity and Laidlaw & Company (UK) Acting as Managers for Oragenics Offering >OGEN
ThinkEquity and Laidlaw & Company (UK) Acting as Managers for Oragenics Offering >OGEN
Oragenics Selling 1.4M Shares of Common Stock at $1.50 Each >OGEN
Oragenics Selling 1.4M Shares of Common Stock at $1.50 Each >OGEN
Oragenics Expects to Raise Gross Proceeds of $2.1M >OGEN
Oragenics Expects to Raise Gross Proceeds of $2.1M >OGEN
Analysis
Price Target
No Data
